Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$94,663,821
+$22,413,129 QoQ
Shares Held
78,924
+0.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
2.68%
of 13F equity value
Holder Rank
#392
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $225,886,114 across 15 Drug Manufacturers - General names. LLY ranks #1 (41.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
78,924 | $94,663,821 | |
| 2 | JNJ |
Johnson & Johnson
|
176,284 | $44,770,847 | |
| 3 | ABBV |
AbbVie Inc.
|
132,322 | $33,297,508 | |
| 4 | MRK |
Merck & Co., Inc.
|
176,330 | $22,658,405 | |
| 5 | AMGN |
Amgen Inc
|
32,937 | $11,927,146 | |
| 6 | NVS |
Novartis AG
|
71,102 | $11,143,105 | |
| 7 | NVO |
Novo Nordisk A S
|
61,839 | $2,964,561 | |
| 8 | PFE |
Pfizer Inc
|
106,893 | $2,573,983 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,663,821 | 78,924 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $72,250,692 | 78,553 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $85,173,771 | 79,255 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $61,165,132 | 80,164 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $56,024,041 | 71,869 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $59,005,488 | 71,443 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $52,971,552 | 68,616 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $62,796,313 | 70,881 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $64,779,939 | 71,550 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $56,276,070 | 72,338 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $41,024,160 | 70,377 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $34,583,652 | 64,386 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $26,810,179 | 57,167 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $19,644,310 | 57,202 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $21,274,327 | 58,152 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $18,269,921 | 56,502 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $17,081,733 | 52,684 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $14,225,716 | 49,676 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $13,431,749 | 48,627 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $11,178,430 | 48,381 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,351,581 | 45,101 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $8,578,961 | 45,921 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,911,971 | 40,938 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $5,543,941 | 37,454 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,289,407 | 38,308 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,929,831 | 35,538 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||